Erythrocyte sedimentation rate

Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America

Retrieved on: 
Tuesday, July 26, 2022
Silicon, Association, Erythrocyte sedimentation rate, ESR, CEO, Partnership, Solution, Marketing, American Association, American Association for Clinical Chemistry, Multimedia, Biotechnology, AACC, Patient, Efficiency, Diesse, Pharmaceutical industry, Medical device, Fine chemical

CHICAGO, July 26, 2022 /PRNewswire/ -- Menarini Silicon Biosystems Inc, a US company part of the Menarini Group and DIESSE Diagnostica Senese Società Benefit S.p.A., a company with over 40 years of experience in the world of laboratory diagnostics, announced today at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo that they have entered into a commercial agreement for the exclusive distribution of the CHORUS TRIO immunometric assay system in the United States of America.

Key Points: 
  • "I am glad that Menarini Silicon Biosystems Inc. will distribute CHORUS in the USA" announced Massimiliano Boggetti CEO of DIESSE.
  • With the broadest range of immunometric mono-test panels, CHORUS TRIO also features technological innovation and Italian design" he added.
  • DIESSE CHORUS line is a great choice to make testing easy, immediate and accurate when lab automation is not an option.
  • Menarini Silicon Biosystems offers unique rare cell technologies and solutions that provide clinicians and clinical researchers with access to unparalleled data on rare cells and their molecular characterization.

Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America

Retrieved on: 
Tuesday, July 26, 2022
Silicon, Association, Erythrocyte sedimentation rate, ESR, CEO, Partnership, Solution, Marketing, American Association, American Association for Clinical Chemistry, Biotechnology, AACC, Patient, Efficiency, Diesse, Pharmaceutical industry, Medical device, Fine chemical

CHICAGO, July 26, 2022 /PRNewswire/ -- Menarini Silicon Biosystems Inc, a US company part of the Menarini Group and DIESSE Diagnostica Senese Società Benefit S.p.A., a company with over 40 years of experience in the world of laboratory diagnostics, announced today at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo that they have entered into a commercial agreement for the exclusive distribution of the CHORUS TRIO immunometric assay system in the United States of America.

Key Points: 
  • "I am glad that Menarini Silicon Biosystems Inc. will distribute CHORUS in the USA" announced Massimiliano Boggetti CEO of DIESSE.
  • With the broadest range of immunometric mono-test panels, CHORUS TRIO also features technological innovation and Italian design" he added.
  • DIESSE CHORUS line is a great choice to make testing easy, immediate and accurate when lab automation is not an option.
  • Menarini Silicon Biosystems offers unique rare cell technologies and solutions that provide clinicians and clinical researchers with access to unparalleled data on rare cells and their molecular characterization.

ALCOR SCIENTIFIC PARTNERS WITH WATER STREET TO ACCELERATE EXPANSION

Retrieved on: 
Wednesday, February 23, 2022
Medtronic, Innovation, Erythrocyte sedimentation rate, Degenerative disease, Water Street, Growth, Inflammation, Investment, Family, Industry, Sale, Johnson & Johnson, Jim Post, PHC, Workflow, Walgreen, Thermo Fisher Scientific, Multimedia, ESR, Leadership, Cancer, Alere, Goal, History, CEO, Research, Infection, Health, Hospital, Medical imaging, Pharmaceutical industry, Management, Alcor, Humana

Alcor Scientific , a leading provider of diagnostic instrumentation and medical devices, announced today that it has partnered with strategic health care investor Water Street Healthcare Partners .

Key Points: 
  • Alcor Scientific , a leading provider of diagnostic instrumentation and medical devices, announced today that it has partnered with strategic health care investor Water Street Healthcare Partners .
  • Water Street has committed significant capital to invest in Alcor's expansion.
  • I'm very pleased to have found in Water Street a strategic partner that values our legacy and will help us build on it.
  • Alcor plans to leverage Water Street's investment to achieve its goals for accelerating the development of new technologies, expanding its product portfolio and bolstering its global reach.

ELITechGroup to exhibit at world's first Virtual Clinical Chemistry Summit

Retrieved on: 
Monday, July 20, 2020
Erythrocyte sedimentation rate, Articles, Health, Medical laboratory scientist, Coronavirus disease, Sedimentation rate

LOGAN, Utah, July 20, 2020 /PRNewswire/ -- ELITechGroup will be exhibiting and presenting to a global online audience at the SelectScience Virtual Clinical Chemistry Summit 2020, taking place July 20-22, 2020.

Key Points: 
  • LOGAN, Utah, July 20, 2020 /PRNewswire/ -- ELITechGroup will be exhibiting and presenting to a global online audience at the SelectScience Virtual Clinical Chemistry Summit 2020, taking place July 20-22, 2020.
  • As COVID-19 forces the postponement of key events, this new Virtual Summitwill offer a crucial forum for clinical lab scientists, healthcare professionals and manufacturers to connect and share the latest diagnostic and point-of-care solutions.
  • We are looking forward to showcasing our Aerospray Slide Stainers and Cytocentrifuges, Osmometers, and Erythrocyte Sedimentation Rate (ESR) instrumentation.
  • The Summit will be open daily from July 20-22, 2020 you can drop in and out as you please.

ELITechGroup to exhibit at world's first Virtual Clinical Chemistry Summit

Retrieved on: 
Monday, July 20, 2020
Erythrocyte sedimentation rate, Articles, Health, Medical laboratory scientist, Coronavirus disease, Sedimentation rate

LOGAN, Utah, July 20, 2020 /PRNewswire/ -- ELITechGroup will be exhibiting and presenting to a global online audience at the SelectScience Virtual Clinical Chemistry Summit 2020, taking place July 20-22, 2020.

Key Points: 
  • LOGAN, Utah, July 20, 2020 /PRNewswire/ -- ELITechGroup will be exhibiting and presenting to a global online audience at the SelectScience Virtual Clinical Chemistry Summit 2020, taking place July 20-22, 2020.
  • As COVID-19 forces the postponement of key events, this new Virtual Summitwill offer a crucial forum for clinical lab scientists, healthcare professionals and manufacturers to connect and share the latest diagnostic and point-of-care solutions.
  • We are looking forward to showcasing our Aerospray Slide Stainers and Cytocentrifuges, Osmometers, and Erythrocyte Sedimentation Rate (ESR) instrumentation.
  • The Summit will be open daily from July 20-22, 2020 you can drop in and out as you please.

Global Autoimmune Disease Diagnostic Markets, 2011-2018 & 2019-2026 by Disease, Tests Type, Regions, Key Company Profiles - ResearchAndMarkets.com

Retrieved on: 
Friday, November 8, 2019
Health, Other Health, Medical specialties, Medicine, Health, RTT, Autoimmune diseases, Autoimmunity, Immunology, Erythrocyte sedimentation rate, Autoimmune disease, Autoantibody

The "Global Autoimmune Disease Diagnostic Market (By Disease, Tests Type, Regions), Key Company Profiles - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Autoimmune Disease Diagnostic Market (By Disease, Tests Type, Regions), Key Company Profiles - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • Multiple sclerosis held highest share of the global localized autoimmune disease diagnostics market, followed by Inflammatory bowel disease segment.
  • Erythrocyte Sedimentation Rate Tests captured around 6% - 8% share of the global autoimmune disease diagnostics market followed by C -reactive protein test.
  • This report provides a comprehensive analysis of the Global Autoimmune Disease Diagnostic Market.